EP 1017722 A2 20000712 - COMPOUNDS WITH ANTI-KS AND ANTI-HIV ACTIVITY
Title (en)
COMPOUNDS WITH ANTI-KS AND ANTI-HIV ACTIVITY
Title (de)
VERBINDUNGEN MIT ANTI-KS UND ANTI-HIV AKTIVITÄT
Title (fr)
COMPOSES A ACTIVITE ANTI-SK ET ANTI-VIH
Publication
Application
Priority
- CA 9800731 W 19980730
- US 5454397 P 19970801
Abstract (en)
[origin: WO9906438A2] The present invention relates to a compound having anti-KS and anti-HIV pharmaceutical activity which comprises an HCG-like inhibitory protein and fragments or derivatives thereof, said protein and fragments thereof are isolated from a biologically active fraction of APL-HCG, wherein said protein has a molecular weight of about 3,500 or of about 13,000 Dalton, and wherein said protein and fragments thereof are adsorbed polypropylene plastic supports. A pharmaceutical composition for the prevention and/or treatment of Kaposi's sarcoma (KS) and HIV which comprises a therapeutically effective amount of at least one compound of the present invention in association with a pharmaceutically acceptable carrier. A method for the prevention, treatment and/or reduction of Kaposi's sarcoma and HIV expression in AIDS patients, which consists in administering the composition to the patient.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); C07K 14/59 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); C07K 14/59 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9906438A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9906438 A2 19990211; WO 9906438 A3 19990408; AU 8526198 A 19990222; CA 2299054 A1 19990211; CN 1271365 A 20001025; EP 1017722 A2 20000712
DOCDB simple family (application)
CA 9800731 W 19980730; AU 8526198 A 19980730; CA 2299054 A 19980730; CN 98809398 A 19980730; EP 98936050 A 19980730